[1]
“Stability indicating RP-HPLC method development and validation for the simultaneous estimation of Grazoprevir and Elbasvir in bulk and pharmaceutical dosage form”, Int. Jrnl.. Res. Pharm. Chem. & Analy, vol. 1, no. 1, pp. 1–7, Jun. 2018, Accessed: Oct. 22, 2025. [Online]. Available: https://rubatosis.org/journals/index.php/ijrpca/article/view/90